---
figid: PMC3731360__pone.0070352.g006
figlink: /pmc/articles/PMC3731360/figure/pone-0070352-g006/
number: Figure 6
caption: 'Panel A: When CLL cells express low CD38, but high CTLA4, CTLA4 inhibits
  the CD38/BCR signaling pathway at multiple levels. CTLA4 downregulates NFATC2 and
  proliferation-associated molecules such as c-Fos and c-Myc. Downregulation of NFATC2
  may also be associated with an autoregulatory loop for CTLA4, which would downregulate
  CTLA4 transcription. CTLA4 also downregulates the expression of Bcl-2, thus decreasing
  the survival of CLL cells. CTLA4 inhibits the expression of STAT1, thus deregulating
  the JAK/STAT pathway and inhibiting CLL cell growth. Panel B: When CLL cells express
  high CD38, but low CTLA4, activated CD38/BCR signaling upregulates downstream molecules
  in the pathway, such as NFATC2, c-Fos, and Bcl-2. These molecules will increase
  proliferation and survival of CLL cells. Low expression of CTLA4 does not interfere
  with the expression of STAT1, which favors CLL cell growth.'
pmcid: PMC3731360
papertitle: Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic
  Leukemia.
reftext: Amit K. Mittal, et al. PLoS One. 2013;8(8):e70352.
pmc_ranked_result_index: '62562'
pathway_score: 0.9083115
filename: pone.0070352.g006.jpg
figtitle: Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia
year: '2013'
organisms: Homo sapiens
ndex: 24f9d77f-df12-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3731360__pone.0070352.g006.html
  '@type': Dataset
  description: 'Panel A: When CLL cells express low CD38, but high CTLA4, CTLA4 inhibits
    the CD38/BCR signaling pathway at multiple levels. CTLA4 downregulates NFATC2
    and proliferation-associated molecules such as c-Fos and c-Myc. Downregulation
    of NFATC2 may also be associated with an autoregulatory loop for CTLA4, which
    would downregulate CTLA4 transcription. CTLA4 also downregulates the expression
    of Bcl-2, thus decreasing the survival of CLL cells. CTLA4 inhibits the expression
    of STAT1, thus deregulating the JAK/STAT pathway and inhibiting CLL cell growth.
    Panel B: When CLL cells express high CD38, but low CTLA4, activated CD38/BCR signaling
    upregulates downstream molecules in the pathway, such as NFATC2, c-Fos, and Bcl-2.
    These molecules will increase proliferation and survival of CLL cells. Low expression
    of CTLA4 does not interfere with the expression of STAT1, which favors CLL cell
    growth.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLCB4
  - PLCB3
  - PLCZ1
  - CTLA4
  - PLCG1
  - PLCD1
  - PLCG2
  - ZAP70
  - CD38
  - FOS
  - MYC
  - PLCB2
  - BCR
  - PLCE1
  - JAK1
  - JAK2
  - VAV3
  - BCL2
  - PLCD3
  - PLCB1
  - NFATC2
  - STAT1
  - TYK2
  - JAK3
  - PLCD4
  - Cancer
genes:
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: CTLA4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: ZAP-70
  symbol: ZAP-70
  source: hgnc_alias_symbol
  hgnc_symbol: ZAP70
  entrez: '7535'
- word: CD38
  symbol: CD38
  source: hgnc_symbol
  hgnc_symbol: CD38
  entrez: '952'
- word: c-Fos
  symbol: c-fos
  source: hgnc_alias_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: Myc.
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: ZAP70
  symbol: ZAP70
  source: hgnc_symbol
  hgnc_symbol: ZAP70
  entrez: '7535'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: VAV3
  symbol: VAV3
  source: hgnc_symbol
  hgnc_symbol: VAV3
  entrez: '10451'
- word: Bcl2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: NFATC2
  symbol: NFATC2
  source: hgnc_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
